Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jan-Feb;24(1):4-9.
doi: 10.5863/1551-6776-24.1.4.

Adverse Drug Reactions in Children: Pediatric Pharmacy and Drug Safety

Adverse Drug Reactions in Children: Pediatric Pharmacy and Drug Safety

Michael Rieder. J Pediatr Pharmacol Ther. 2019 Jan-Feb.

Abstract

An underappreciated problem in child health is the risk for adverse drug reactions (ADRs). While there is an impression that children are at a lower risk than adults for ADRs, in fact a number of factors germane to pediatric therapy place certain groups of children at a high risk for adverse events associated with therapy. Given the importance of drug safety, an understanding of a diagnostic classification for ADRs and of how to approach a possible ADR clinically are key skills for pediatric pharmacists. As drug therapy for children evolves, becomes more complex, and begins to use novel molecules and biologicals there will be an increasing need for pediatric pharmacists to be more involved in clinical care, education, and research specific to drug safety.

PubMed Disclaimer

Conflict of interest statement

Disclosures The author declares no conflict or financial interest in any product or service mentioned in the manuscript, including grants, equipment, medication, employment, gifts, and honoraria.

Similar articles

Cited by

References

    1. Rieder MJ. If children ruled the pharmaceutical industry: the need for pediatric formulations. Drug News Perspect. 2010;23(7):458–464. - PubMed
    1. Weinshilboum RM. The therapeutic revolution. Clin Pharmacol Ther. 1987;42(2):481–484. - PubMed
    1. Thomas L. The Youngest Science: Notes of a Medicine Watcher. London, England: Penguin Books; 1995.
    1. Rieder MJ. Pathophysiology of drug hypersensitivity: implications for therapy. Expert Opin Drug Safety. 2009;8:331–343. - PubMed
    1. Ballentine C. Sulfanilamide Disaster. FDA Consumer magazine June 1981 Issue at https://www.fda.gov/aboutfda/whatwedo/history/productregulation/sulfanil... Accesseb November 19, 2018.

LinkOut - more resources